Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Principles of Disease Surveillance

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reimagining Paediatric HIV Care: Centering Infants and Young Children in Optimized, Integrated Models of Care.

Journal of the International AIDS Society·2026

Same author

Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Same author

Genomic epidemiology of the 2025 mpox epidemic in Sierra Leone.

Nature medicine·2026

Same author

Constitutive and inducible fibrosis explain immune variation among threespine stickleback populations.

bioRxiv : the preprint server for biology·2026

Same author

The future of diagnostics in Africa.

Nature medicine·2026

Same author

Measuring capacities to advance global health security and bioeconomic development on the African continent.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Same journal

NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

The Journal of infectious diseases·2026

Same journal

Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions.

The Journal of infectious diseases·2026

Same journal

Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

The Journal of infectious diseases·2026

Same journal

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

The Journal of infectious diseases·2026

Same journal

Type 3 fimbrial regulation underpins anti-MrkA immunotherapeutic efficacy in experimental Klebsiella pneumoniae infection.

The Journal of infectious diseases·2026

Same journal

Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

The Journal of infectious diseases·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 3, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

Building Integrated Testing Programs for Infectious Diseases.

George Alemnji^1,2, Fausta Mosha³, Paolo Maggiore⁴

¹Office of the Global AIDS Coordinator and Health Diplomacy, US Department of State, Washington, District of Columbia, USA.

The Journal of Infectious Diseases

|April 12, 2023

Summary

This summary is machine-generated.

Integrated disease testing improves healthcare and pandemic preparedness by breaking down disease-specific silos. Overcoming barriers like funding and policy alignment is key to implementing multi-disease testing systems.

Keywords:

COVID-19 HIV TB diagnostics integration

More Related Videos

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Related Experiment Videos

Last Updated: Aug 3, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Area of Science:

Public Health
Infectious Disease Diagnostics
Health Systems Strengthening

Background:

Disease-specific testing programs for HIV, tuberculosis, and malaria have expanded but remain siloed.
Siloed testing leads to suboptimal capacity, reduced efficiency, and limited outbreak response capabilities.
The demand for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing highlighted the potential of integrated testing.

Purpose of the Study:

To advocate for an integrated public laboratory infrastructure for multi-disease testing.
To identify barriers to integrated testing and propose strategies for overcoming them.
To improve universal healthcare delivery and pandemic preparedness through integrated diagnostics.

Main Methods:

Analysis of existing disease-specific testing models.
Evaluation of the SARS-CoV-2 testing experience as a case study for integration.
Identification of policy, funding, and health system alignment challenges.
Proposal of strategies including policy implementation, network optimization, and procurement reform.

Main Results:

Integrated testing is feasible and offers significant advantages over siloed approaches.
Barriers to integration include misaligned health systems, funding issues, and policy gaps.
Successful integration requires strategic planning and policy support.
Key strategies include optimizing diagnostic networks and bundled procurement.

Conclusions:

An integrated laboratory infrastructure is crucial for efficient universal healthcare and pandemic preparedness.
Overcoming systemic barriers through policy, funding, and network optimization is essential for successful multi-disease testing.
Adoption of integrated testing models will enhance diagnostic capacity and response to future health threats.